Affect lability and Multiple sclerosis relapse

Summary:

Multiple sclerosis relapse is found among people with Affect lability, especially for people who are female, 50-59 old.

The study analyzes which people have Multiple sclerosis relapse with Affect lability. It is created by eHealthMe based on reports of 12 people who have Affect lability from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Affect lability?

Affect lability (emotional incontinence) is found to be associated with 804 drugs and 805 conditions by eHealthMe. Check the latest studies of Affect lability.

What is Multiple sclerosis relapse?

Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,112 drugs and 928 conditions by eHealthMe. Check the latest studies of Multiple sclerosis relapse.



On Oct, 29, 2025

12 people who have Affect Lability and Multiple Sclerosis Relapse are studied.

Would you have Multiple sclerosis relapse when you have Affect lability?

Gender of people who have Affect Lability and experienced Multiple Sclerosis Relapse *:

  • female: 66.67 %
  • male: 33.33 %

Age of people who have Affect Lability and experienced Multiple Sclerosis Relapse *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 50 %
  • 40-49: 0.0 %
  • 50-59: 50 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 75.00%
  2. Depression: 3 people, 25.00%
  3. Hypersensitivity: 3 people, 25.00%
  4. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 3 people, 25.00%
  5. Upper Respiratory Tract Infection: 2 people, 16.67%
  6. Erection Problems: 2 people, 16.67%
  7. Fatigue (feeling of tiredness): 2 people, 16.67%
  8. High Blood Pressure: 2 people, 16.67%
  9. Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 16.67%
  10. Movement - Uncoordinated: 2 people, 16.67%

Common drugs taken by these people *:

  1. Nuedexta: 11 people, 91.67%
  2. Avonex: 5 people, 41.67%
  3. Copaxone: 3 people, 25.00%
  4. Tysabri: 3 people, 25.00%
  5. Tylenol: 3 people, 25.00%
  6. Tecfidera: 3 people, 25.00%
  7. Ampyra: 2 people, 16.67%
  8. Keppra: 2 people, 16.67%
  9. Neurontin: 2 people, 16.67%
  10. Flaxseed: 2 people, 16.67%

Common symptoms for these people *:

  1. Weakness: 3 people, 25.00%
  2. The Flu (the flu is caused by an influenza virus): 3 people, 25.00%
  3. Leukopenia (less number of white blood cells in blood): 2 people, 16.67%
  4. Nosebleed (bleeding from nose): 2 people, 16.67%
  5. Fever: 2 people, 16.67%
  6. Gait Disturbance: 2 people, 16.67%
  7. Hair Loss: 2 people, 16.67%
  8. Herpes Zoster: 2 people, 16.67%
  9. High Blood Pressure: 2 people, 16.67%
  10. Hot Flush (sudden feelings of heat): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Multiple sclerosis relapse?

Check whether Multiple sclerosis relapse is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Multiple sclerosis relapse:

All the conditions that are associated with Multiple sclerosis relapse:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Multiple sclerosis relapse and Affect lability, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: